Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 127Precursor Cell Lymphoblastic Leukemia-Lymphoma 45Myelodysplastic Syndromes 25Leukemia 25Burkitt Lymphoma 25Leukemia, Biphenotypic, Acute 20Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 14Lymphoma, Mantle-Cell 14Recurrence 13Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 10Myeloproliferative Disorders 9Lymphoma 9Lymphoma, Non-Hodgkin 8Leukemia, Myelomonocytic, Chronic 8Lymphoma, Large B-Cell, Diffuse 7Down Syndrome 6Neoplasm, Residual 5Hodgkin Disease 5Blast Crisis 5Sarcoma, Myeloid 4Lymphoma, T-Cell 4Leukemia, Monocytic, Acute 4Hematologic Neoplasms 4Lymphoma, Follicular 3Leukemia, Myelomonocytic, Juvenile 3Leukemia, Myelomonocytic, Acute 3Leukemia, Myeloid, Accelerated Phase 3Neoplasms 2Multiple Myeloma 2Lymphoma, B-Cell 2

Interventions

Azacitidine 2aldesleukin 1Whole-Body Irradiation 1Vorinostat 1Peripheral Blood Stem Cell Transplantation 1Idarubicin 1Gemtuzumab 1Filgrastim 1Etoposide 1Cytarabine 1Busulfan 1Bone Marrow Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Megakaryoblastic, Acute × Cytarabine × 1 year × Clear all
NCT00534469 2025-12-02

Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R

City of Hope Medical Center

Phase 2 Completed
60 enrolled 9 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡